Juno Therapeutics

Global biopharmaceutical company discovering, developing, and delivering innovative medicines

placeSeattle, Washington, United States calendar_todayFounded 2013 groups730 employees language junotherapeutics.com

Registered entities

Innovation

181 patent families (80 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing, Operations & transport; filing pace slowing. Cited 64,938 times.

YearFilings
20153
201612
201726
201847
201973
202072
202176
202275
202385
202474
202577
202623

Investor mix

16 investors on record; 1 has since exited.

Investor typeCountShare
Venture capital956%
Private equity425%
Other / undisclosed319%
Coming soon